arrow
返回

Super free fall

delete2009-12-15
delete10
PRE
AI
E
Emmanuel Villermaux *
Y
Yves Pomeau
DOI:10.1017/S0022112009992424delete
delete原文链接
delete原文求助
delete分享
delete收藏
摘要

摘要

En 中文
The free fall of a liquid mass through vertical tubes with a weakly increasing cross-section induces an acceleration of the upper liquid interface larger than gravity. The phenomenon is well described by a one-dimensional inviscid model. The super acceleration of the upper interface comes from the additional positive pressure gradient caused by the expanding geometry, which adds to the gravity body force. A perturbative expansion of this base solution further accounts for the interface shape and stability. In particular, the positive pressure gradient at the interface makes it unstable, forming a concentrated 'nipple' on top of the essentially flat base solution. We discuss the possible connexion of these findings with the problem of wave breaking in free surface flows.
Keyword:
free surface flows
stability Rayleigh-Taylor instability
tubes superacceleration
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Journal of Fluid Mechanics 封面图
Journal of Fluid Mechanics
IF:
3.9
论文数:
2.0W
被引数:
9.4W

机构

U
University of Arizona
学者数:
3.6W
论文数: 3.2W
被引数: 980
A
aix-marseille universite
学者数:
3.8W
论文数: 2.7W
被引数: 77
引用论文

引用论文

err分享
err收藏
err分享
err收藏
Bleeding Complications and Adverse Events After Desmopressin Acetate for Percutaneous Renal Transplant Biopsy
err2020-02-29
err0
errOAAI
errQuan Yao Ho; Cynthia C Lim; Sobhana Thangaraju; Benson Siow; Yok Mooi Chin; Ying Hao; Puay Hoon Lee; Marjorie Foo; Chieh Suai Tan; Terence Kee
err分享
err收藏
err
IF0
err
err0
PREAI
err
err分享
err收藏
Hematotoxic, oxidative and genotoxic damage in rainbow trout (Oncorhynchus mykiss) after exposure to 3-benzoylpyridine
err2022-03-10
err0
PREAI
errVeysel Parlak; Bünyamin Ozgeris; Arzu Ucar; Aslı Cilingir Yeltekin; Fatma Betul Ozgeris; Ozge Cağlar; Gonca Alak; Hasan Turkez; Muhammed Atamanalp
err分享
err收藏
Health‐related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial
err2021-02-08
err0
errOAAI
errVania Hungria; Meral Beksac; Katja C. Weisel; Ajay K. Nooka; Tamas Masszi; Ivan Spicka; Markus Munder; María‐Victoria Mateos; Tomer M. Mark; Ming Qi; Xiang Qin; John Fastenau; Andrew Spencer; Pieter Sonneveld; Wendy Garvin; Thomas Renaud; Katharine S. Gries
err分享
err收藏
没有更多内容